Biotech

All Articles

Kairos goes social along with $6M IPO to cash trials of cancer drug

.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually effortless to miss out...

Vaccine and Keytruda combo efficient in squamous tissue carcinoma

.Invulnerable gate preventions are actually the superheroes of cancer therapy. Medications like Bris...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings...

Regeneron's Opdualag competitor shows 57% action price

.Regeneron is actually back along with long-lasting follow-up for its LAG-3 inhibitor as well as PD-...

AstraZeneca blog posts records on in-house competitors to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed an early look at the performance of its internal antibody-drug c...

iTeos- GSK's TIGIT celebrity shows purposeful remodeling

.After declaring a phase 3 launch based on beneficial midstage end results, iTeos and also GSK are a...

More collective FDA can easily accelerate uncommon condition R&ampD: report

.The FDA ought to be extra available and collaborative to let loose a surge in approvals of unusual ...

Zenas, MBX, Bicara scalp to Nasdaq in very hot time for biotech IPOs

.It's an uncommonly busy Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Rehabs all go...

Atea's COVID antiviral stops working to stop hospital stays in phase 3

.Atea Pharmaceuticals' antiviral has stopped working an additional COVID-19 trial, but the biotech s...

Neurocrine's quote to conserve mental illness possibility stops working

.Neurocrine Biosciences' schizophrenia system pivot has actually stopped working. The biotech was in...